CareDx, Inc. Cash Flow Statement
CDNA / Health Care|14 years of annual SEC 10-K data (FY2012-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 14 fiscal years. All figures from audited SEC 10-K filings.
CareDx, Inc. generated $42M in operating cash flow in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$21.4M | $52.5M | -$190.3M | -$76.6M | -$30.7M | -$18.7M | -$22.0M | -$46.8M | -$55.5M | -$39.5M | -$13.7M | $781.0K | -$3.5M | -$5.1M |
| Depreciation & Amortization | $15.0M | $14.2M | $14.4M | $11.6M | $8.8M | $7.0M | $5.5M | $4.2M | $3.7M | $2.9M | $796.0K | $512.0K | $663.0K | $1.1M |
| Operating Cash Flow | $42.0M | $38.0M | -$18.4M | -$25.2M | -$19.3M | $33.4M | -$2.8M | -$4.0M | -$14.3M | -$16.5M | -$9.8M | -$3.4M | -$546.0K | -$1.8M |
| Capital Expenditures | - | - | $1.8M | - | - | - | - | $2.0M | $186.0K | $549.0K | $1.2M | $733.0K | $98.0K | $141.0K |
| Free Cash Flow | - | - | -$20.2M | - | - | - | - | -$6.0M | -$14.5M | -$17.1M | -$11.0M | -$4.1M | -$644.0K | -$1.9M |
| Share Buybacks | $87.8M | $522.0K | $27.5M | $642.0K | $0 | $0 | - | - | - | - | - | - | - | - |
| FCF Margin | - | - | -7.2% | - | - | - | - | -7.9% | -125.1% | -136.8% | -38.9% | -14.9% | -2.9% | -9.4% |